MAK Capital Fund LP Beneficial Ownership Filing for ClearPoint Neuro, Inc.

MAK Capital Fund LP, along with MAK Capital One L.L.C. and Michael A. Kaufman, collectively known as the Reporting Persons, has filed a Schedule 13G detailing their beneficial ownership of ClearPoint Neuro, Inc. common stock. As of March 13, 2026, the Reporting Persons beneficially own 1,729,611 shares, representing 6.1% of the outstanding common stock. This ownership stake was calculated based on the total outstanding shares as of October 27, 2025. The filing indicates that the shares were acquired and are held without the purpose or effect of changing or influencing the control of the issuer.